BioNTech SE Comprehensive Income
BioNTech SE (BNTX) reported Comprehensive Income of -EUR 1.25 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Income Statement › Unrealized Gains
ifrs-full:ComprehensiveIncome · last filed 2026-03-10
| Period end | Comprehensive Income 12 month | Comprehensive Income 12 month as first filed |
|---|---|---|
| 2025-12-31 | -1.25B EUR 20-F · filed 2026-03-10 | |
| 2024-12-31 | -768.40M EUR 20-F · filed 2026-03-10 | |
| 2023-12-31 | 914.50M EUR 20-F · filed 2026-03-10 | |
| 2022-12-31 | 9.46B EUR 20-F · filed 2025-03-10 | |
| 2021-12-31 | 10.30B EUR 20-F · filed 2024-03-20 | |
| 2020-12-31 | 3.80M EUR 20-F · filed 2023-03-27 | 3.83M EUR 20-F · filed 2021-03-30 |
| 2019-12-31 | -179.10M EUR 20-F/A · filed 2022-10-26 | -179.09M EUR 20-F · filed 2020-03-31 |
| 2018-12-31 | -48.25M EUR 20-F · filed 2021-03-30 | |
| 2017-12-31 | -85.97M EUR 20-F · filed 2020-03-31 |